| |
| |
|
| Insider
Information: |
Dobmeier Eric |
| Relationship: |
President, CEO, Director |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
730,812 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$28,060,467 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
730,812 |
|
|
| Total
Value |
$28,060,467 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
13
|
3
|
|
Stock
price went up :
|
7
|
3
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.2
|
3.0
|
| Percentage
Gain/Loss : |
 17.0%
|
198.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
Chief Operating Officer |
2017-12-04 |
119,860 |
2004-05-05 |
0 |
Premium* |
|
|
Stemline Therapeutics Inc |
STML |
Director |
2017-06-19 |
27,963 |
|
0 |
Premium* |
|
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2023-11-10 |
563,325 |
2015-12-16 |
0 |
Premium* |
|
|
Aravive Inc |
ARAV |
Director |
2017-12-20 |
18,160 |
2017-05-25 |
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2021-02-14 |
1,504 |
2019-12-26 |
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
President, CEO, Director |
2023-08-11 |
0 |
2020-10-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
177 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2019-12-31 |
4 |
OE |
$6.32 |
$31,600 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2020-05-07 |
4 |
OE |
$6.32 |
$31,600 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2020-05-19 |
4 |
OE |
$6.32 |
$31,600 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2020-06-03 |
4 |
OE |
$6.32 |
$31,600 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
OE |
$5.25 |
$57,750 |
D/D |
11,000 |
5,098 |
0 |
- |
|
| SGEN |
Seagen Inc |
Sr. VP, Corporate Development |
• – – |
2007-02-09 |
4 |
OE |
$2.70 |
$184,395 |
D/D |
43,472 |
5,198 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
OE |
$4.45 |
$213,389 |
D/D |
44,400 |
5,198 |
0 |
- |
|
| SGEN |
Seagen Inc |
V. P., Corporate Affairs |
• – – |
2004-06-21 |
4 |
OE |
$5.25 |
$26,250 |
D/D |
5,000 |
5,300 |
|
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2016-03-17 |
4 |
B |
$13.86 |
$41,565 |
D/D |
3,000 |
5,500 |
2.39 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
OE |
$5.25 |
$86,625 |
D/D |
16,500 |
5,598 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,960 |
6,960 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
7,500 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Director |
– • – |
2013-01-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,963 |
|
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2011-06-20 |
4 |
AS |
$20.00 |
$267,700 |
D/D |
(13,385) |
8,817 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2008-09-26 |
4 |
S |
$11.53 |
$281,575 |
D/D |
(24,427) |
9,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2020-07-06 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2020-10-01 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2021-01-04 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2009-07-29 |
4 |
S |
$12.36 |
$324,755 |
D/D |
(26,266) |
12,206 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2009-07-30 |
4 |
S |
$12.36 |
$417,050 |
D/D |
(33,734) |
12,206 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
12,500 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2008-09-29 |
4 |
OE |
$5.25 |
$26,250 |
D/D |
5,000 |
14,000 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2018-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
14,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2019-12-26 |
4 |
OE |
$6.32 |
$94,800 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2019-06-27 |
4 |
B |
$19.50 |
$39,000 |
D/D |
2,000 |
16,000 |
2.39 |
- |
|
177 Records found
|
|
Page 2 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
